Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone marrow transplantation for hematologic malignancies

K G Blume, S J Forman

    Journal of Cellular Physiology. Supplement
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Autologous stem-cell transplantation after second-line brentuximab vedotin in relapsed or refractory Hodgkin lymphoma.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017
    Same author

    Redirecting T cells to eradicate B-cell acute lymphoblastic leukemia: bispecific T-cell engagers and chimeric antigen receptors.

    Leukemia·2016
    Same author

    Mycophenolate mofetil-based salvage as acute GVHD prophylaxis after early discontinuation of tacrolimus and/or sirolimus.

    Bone marrow transplantation·2014
    Same author

    Sclerodermatous chronic GVHD in patients receiving tyrosine kinase inhibitors after allogeneic hematopoietic cell transplantation.

    Bone marrow transplantation·2014
    Same author

    Real-time assessment of relapse risk based on the WT1 marker in acute leukemia and myelodysplastic syndrome patients after hematopoietic cell transplantation.

    Bone marrow transplantation·2014
    Same author

    Efficient selection of genetically modified human T cells using methotrexate-resistant human dihydrofolate reductase.

    Gene therapy·2013
    Same journal

    The Yang and Yin of cell proliferation: an overview.

    Journal of cellular physiology. Supplement·1987
    Same journal

    Distribution of fibroblast growth factors (FGFs) in tissues and structure-function studies with synthetic fragments of basic FGF.

    Journal of cellular physiology. Supplement·1987
    Same journal

    Molecular bases for the regulation of cellular growth, differentiation, and transformation. Proceedings of a conference. Coconut Grove, Florida, November 10 and 11, 1986.

    Journal of cellular physiology. Supplement·1987
    Same journal

    Immunological mediators of wound healing and fibrosis.

    Journal of cellular physiology. Supplement·1987
    Same journal

    A repetitive sequence element 3' of the human c-Ha-ras1 gene has enhancer activity.

    Journal of cellular physiology. Supplement·1987
    Same journal

    Inhibition of cell surface ruffling and fluid-phase pinocytosis by microinjection of anti-ras antibodies into living cells.

    Journal of cellular physiology. Supplement·1987
    See all related articles

    Allogeneic and syngeneic bone marrow transplantation is a key treatment for hematologic malignancies. Early intervention in bone marrow grafting yields optimal clinical outcomes for patients with leukemia, lymphoma, and myelosclerosis.

    Area of Science:

    • Hematology
    • Oncology
    • Transplantation Medicine

    Background:

    • Bone marrow transplantation (BMT) is an established therapy for hematologic malignancies.
    • Over 500 patients worldwide have undergone BMT for conditions including leukemia, lymphoma, and myelosclerosis.
    • Significant clinical challenges remain in current BMT practices.

    Purpose of the Study:

    • To highlight the role of allogeneic and syngeneic bone marrow transplantation in treating hematologic malignancies.
    • To emphasize the importance of early intervention in bone marrow grafting procedures.
    • To underscore the current clinical landscape and challenges associated with BMT.

    Main Methods:

    • Review of clinical outcomes in over 500 patients undergoing bone marrow transplantation.

    Related Experiment Videos

  • Analysis of treatment efficacy for various hematologic malignancies.
  • Identification of factors influencing optimal results in BMT.

    • Main Results:

    • Bone marrow transplantation is a vital treatment modality for acute myelogenous leukemia, lymphoblastic leukemia, chronic granulocytic leukemia, acute malignant myelosclerosis, and lymphoma.
    • Early performance of marrow grafting is associated with optimal clinical results.
    • Despite advancements, BMT is associated with significant clinical challenges.

    Conclusions:

    • Bone marrow transplantation remains a critical therapeutic option for specific hematologic malignancies.
    • Timely initiation of marrow grafting is crucial for maximizing patient outcomes.
    • Further research is needed to address the persistent clinical challenges in BMT.